SCHEMBL2803136

SCHEMBL2803136

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3cc(C)ccc3C)c(C(=O)N3CC=C(c4ccc(F)cc4)CC3)cnc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
HPGD P15428 3/20 0.34
USP2 O75604 2/20 0.34
TSHR P16473 2/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 1/20 0.34
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
NAMPT P43490 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800783 0.89 MAPT (0.39) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL2801522 0.88 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AHPGDUSP2
SCHEMBL2803803 0.86 FASN (0.40) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL2802527 0.84 SPR (0.37) MEN1KMT2A
SCHEMBL2803840 0.81 HPGD (0.36) ALDH1A1HPGDKDM4EPOLBHSD17B10
SCHEMBL2799817 0.80 FASN (0.36) TP53MAPTLMNATHRB
SCHEMBL2801670 0.80 FASN (0.39) ALDH1A1TP53MAPTNPC1RAB9A
SCHEMBL2801581 0.80 ALDH1A1 (0.33) ALDH1A1MEN1KMT2AHPGDUSP2
SCHEMBL2800861 0.80 TP53 (0.39) ALDH1A1KMT2APOLBTP53MAPT
SCHEMBL2803131 0.79 TP53 (0.38) ALDH1A1HPGDUSP2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 ALDH1A1 243/4885MEN1 3065/4885KMT2A 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.